Earnings Estimates

Glossary »

Stock Information

Price (Prev Close) 1,428.00
Price - 52 Week High 1,489.00
Price - 52 Week Low 970.00
Price Date (Latest) Jun 28, 2017
Median Price Target 1,500.00
Diff from Prev Close 72.00
% Difference 5.04%

Reference Information

Last Actual (FY0) 19.22
FY0 End Date Dec '16
Indicated Annual Div. N/A
Hist (5 Yr) Growth % 66.67 %
Hist (5 Yr) Stability % 185.26 %
Yield (%) N/A

 

Analyst Forecasts

Last Month Revisions
Fiscal Period Mean High Low Median # of Estimates # Up # Down Mean % Change
Annual
Dec '19
54.07 93.40 36.57 50.92 13 0 0 -1.31 %
Annual
Dec '18
34.57 45.00 23.22 33.59 12 1 0 0.55 %
Annual
Dec '17
20.43 23.50 16.20 20.98 13 0 1 -1.24 %
Quarterly
Jun '17
5.79 6.68 4.90 5.79 2 0 0 -  
Quarterly
Sep '17
2.48 4.16 0.80 2.48 2 0 0 -  
Quarterly
Dec '17
10.52 10.85 10.20 10.52 2 0 0 -  
Long Term Growth
N/A
34.74 45.70 22.30 35.48 4 0 0 -  

 

Actuals

Fiscal Period Reported EPS Mean Estimates Surprise % Change
Annual
Dec '16
19.22 15.79 21.70 %
Quarterly
Jun '16
2.72 1.68 62.32 %
Quarterly
Sep '16
3.06 1.11 175.18 %
Quarterly
Dec '16
13.62 7.36 85.12 %
Quarterly
Mar '17
0.26 -0.19 240.54 %
Annual
Dec '15
12.56 11.26 11.54 %
Annual
Dec '14
5.26 4.05 29.88 %

 

P/E Ratios

Genmab A/S - eafe hea multi-industry

Fiscal Period Genmab A/S eafe hea multi-industry Industry Relative
FY0 74.30 57.39 1.29
FY1 69.88 53.98 1.29
FY2 41.30 31.90 1.29

 

EPS Growth Rates

Genmab A/S - eafe hea multi-industry

Growth Rates Genmab A/S eafe hea multi-industry Industry Relative
FY1/FY0 6.32 6.32 1.00
FY2/FY1 69.19 69.19 1.00
FY3/FY2 56.39 56.39 1.00

Disclaimer: Mean earnings estimates are calculated by First Call based on their earnings projections made by the analysts who cover Genmab A/S. Please note that any opinions, estimates or forecasts regarding Genmab A/S's performance made by these analysts (and therefore the average estimate numbers) are theirs and do not represent opinions, forecasts or predictions of Genmab A/S or its management. Genmab A/S does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Prices are in DKK